These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4278395)

  • 1. Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds.
    Thorsen S; Müllertz S
    Scand J Clin Lab Invest; 1974 Oct; 34(2):167-76. PubMed ID: 4278395
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of different D-and E-antigenic intermediates during plasmin degradation of non-stabilized and stabilized fibrin clots.
    Gormsen J; Feddersen C
    Scand J Haematol; 1973; 10(5):337-48. PubMed ID: 4272382
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid.
    Sjöholm I
    Eur J Biochem; 1973 Nov; 39(2):471-9. PubMed ID: 4272770
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis induction by synthetic organic acids. Chemical structure and biological activity relationship.
    Cepelák V; Roubal Z; Kuchar M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):343-50. PubMed ID: 63420
    [No Abstract]   [Full Text] [Related]  

  • 5. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A; Straub PW
    Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
    [No Abstract]   [Full Text] [Related]  

  • 6. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
    Gormsen J; Feddersen C
    Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
    [No Abstract]   [Full Text] [Related]  

  • 7. Research on the mechanism of synthetic thrombolytic agents.
    Desnoyers P; Labaume J; Conard J; Samama M
    Acta Univ Carol Med Monogr; 1972; 52():33-40. PubMed ID: 4273930
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative determination of plasminogen. A caseinolytic method.
    Bruhn HD; Müller L; Duckert F
    Thromb Diath Haemorrh; 1970 May; 23(2):191-201. PubMed ID: 4246602
    [No Abstract]   [Full Text] [Related]  

  • 9. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.
    Claeys H; Vermylen J
    Biochim Biophys Acta; 1974 Apr; 342(2):351-9. PubMed ID: 4275496
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide.
    Walther PJ; Steinman HM; Hill RL; McKee PA
    J Biol Chem; 1974 Feb; 249(4):1173-81. PubMed ID: 4273519
    [No Abstract]   [Full Text] [Related]  

  • 11. A partially degraded form of human plasminogen in circulating blood.
    Yamamoto J; Okamoto U; Kojima S; Morita S; Fujii K
    Clin Lab Haematol; 1982; 4(2):117-30. PubMed ID: 6214361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
    Sasaoka M; Wada Y; Hasumi K
    J Antibiot (Tokyo); 2007 Nov; 60(11):674-81. PubMed ID: 18057696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction of serum inhibitor of activator-induced clot lysis from alpha1-antitrypsin.
    Aoki N; Moroi M
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):567-70. PubMed ID: 4275737
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of porcin plasminogen by human urokinase.
    Lauritsen OS
    Scand J Clin Lab Invest; 1968; 22(3):239-46. PubMed ID: 4237138
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis.
    Ambrus JL; Ambrus CM; Sharma SD; Suh OW; Gastpar H
    J Med; 1982; 13(5-6):365-71. PubMed ID: 6221055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptokinase and urokinase activation of human, chimpanzee and baboon plasminogen.
    McKee PA; Lemmon WB; Hampton JW
    Thromb Diath Haemorrh; 1971 Dec; 26(3):512-22. PubMed ID: 5004225
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the fibrinolytic activity in human semen studied by gel filtration.
    Hisazumi H
    Invest Urol; 1970 Mar; 7(5):410-21. PubMed ID: 5461871
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the purification and characterization of human urinary plasminogen and plasmin.
    Chen HF; Nakabayashi M; Satoh K; Sakamoto S
    Thromb Haemost; 1980 Feb; 42(5):1536-47. PubMed ID: 6445089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic capacity in human plasma. I. Measurement of proteolytic activity in the presence of natural inhibitors and study of the inter-individual variations.
    Jacobsen CD
    Scand J Clin Lab Invest; 1968; 21(3):216-26. PubMed ID: 4236912
    [No Abstract]   [Full Text] [Related]  

  • 20. Degradation of bovine factor 8 by plasmin and trypsin.
    Kirby EP; Martin N; Marder VJ
    Blood; 1974 May; 43(5):629-40. PubMed ID: 4274479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.